Platforms
– Center in pharmaco(epi)genomics: next-generation sequencing, whole genome and targeted methylome analysis, transcriptomics, metagenomics
– miRNA/lnc RNA platform
– Diagnostic sequencing: targeted resequencing
– glycomics
– proteomics
– Cancer invasion assays
– zebrafish screening platform
Biomarker validation teams and collaborations expertise domains:
– Cancer (Colorectal cancer, Breast cancer, Melanoma, Neuroblastoma, Leukemia)
– Inflammatory diseases
– Diabetes
Techtransfer expertise, FTO analysis, Licensing, Valorisation, networking
